Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ...

The chaos Health and Human Services Secretary Robert Kennedy has injected into the U.S. vaccine market could have long-term ...

China’s National Medical Products Administration (NMPA) has issued guidance governing online sales of medical devices with a ...

It appears that Staar Surgical Co.'s proposed $1.6 billion merger with Alcon AG has been scrapped as Starr shareholders voted ...

Eye disease specialist Oculis SA is laying plans to branch out into multiple sclerosis (MS) after the phase II trials of its acute optic neuritis (AON) drug, privosegtor, showed it reduced levels of ...

Software as a service has typically been less susceptible to liability than products, but that may soon come to an end if the AI LEAD Act, sponsored by a bipartisan pair of members of the Senate, ...

It doesn’t take a meteorologist to predict another stormy year for the biopharma sector, not just in the U.S., but also in ...

The newly released 2026 edition of Clarivate’s Drugs to Watch report highlights 11 potential blockbusters that could change treatment paradigms for patients.

Naox Technologies SAS secured U.S. FDA 510(k) clearance for Naox Link, its in-ear electroencephalography (EEG) device for clinical use both at home and in health care settings. Naox Link is a pair of ...

Biopharma industry zeal for obesity therapeutics does not appear to be dying down any time soon, with Eli Lilly and Co. entering a $1.3 billion deal with Nimbus Therapeutics LLC for a new small ...